| REVIEW |
|
| Year : 2021 | Volume
: 11
| Issue : 2 | Page : 83-87 |
|
|
Recent advances in the protective role of hydrogen sulfide in myocardial ischemia/reperfusion injury: a narrative review
Meng-Ling Zhang1, Wei Peng1, Jian-Qiang Ni1, Gang Chen2
1 Department of Neurology, The First Affiliated Hospital of Soochow University, Suzhou, Jiangsu Province, China
2 Department of Neurosurgery & Brain and Nerve Research Laboratory, The First Affiliated Hospital of Soochow University, Suzhou, Jiangsu Province, China
Correspondence Address:
Jian-Qiang Ni
Department of Neurology, The First Affiliated Hospital of Soochow University, Suzhou, Jiangsu Province
China
 Source of Support: None, Conflict of Interest: None  | Check |
DOI: 10.4103/2045-9912.311499
|
|
|
Hydrogen sulfide (H2S) is recognized to be a novel mediator after carbon monoxide and nitric oxide in the organism. It can be produced in various mammalian tissues and exert many physiological effects in many systems including the cardiovascular system. A great amount of recent studies have demonstrated that endogenous H2S and exogenous H2S-releasing compounds (such as NaHS, Na2S, and GYY4137) provide protection in many cardiovascular diseases, such as ischemia/reperfusion injury, heart failure, cardiac hypertrophy, and atherosclerosis. In recent years, many mechanisms have been proposed and verified the protective role exhibited by H2S against myocardial ischemia/reperfusion injury, and this review is to demonstrate the protective role of exogenous and endogenous H2S on myocardial ischemia/reperfusion injury.
|
|
|
|
| [FULL TEXT] [PDF]* |
|
 |
|
Next article
